Tuning the moenomycin pharmacophore to enable discovery of bacterial cell wall synthesis inhibitors

Article abstract of DOI:10.1021/ja4000933

New antibiotic drugs need to be identified to address rapidly developing resistance of bacterial pathogens to common antibiotics. The natural antibiotic moenomycin A is the prototype for compounds that bind to bacterial peptidoglycan glycosyltransferases